Pamisel, Stock Price 18,300 Won.. Down 5.91% Compared to Previous Day
As of 9:30 AM on the 19th, Pamicell is trading at 18,300 KRW, down 5.91% from the previous day. This represents a 24.07% decline compared to May 29. Pamicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Over the past five days, individual investors have net purchased 200,607 shares, while foreigners and institutions have net sold 162,981 shares and net purchased 435 shares, respectively.
On June 17, Pamicell was a market topic due to news about the effectiveness of 'Dexamethasone' in treating COVID-19, which led to a weak performance.
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- After Losing Her Only Daughter, a Mother in China Gave Birth to Twins at 60... Reinventing Life at 76
- KOSPI Plunges, Sell-Side Sidecar Triggered for Second Consecutive Trading Day
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
